Sudarshan Sukhani of s2analytics.com is of the view that one can buy Ajanta Pharma and Tech Mahindra and can sell BEML, CESC and India Cements.
Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Ajanta Pharma is a buying opportunity, this is about the pharma theme. A lot of pharma stocks are giving bullish signals and willing to breakout and suggesting an upmove is coming. So, pharma is likely to do its own thing. Focus on the sector."
"Tech Mahindra is a buying opportunity there. Pharma now is likely to do what IT had done earlier, a strong rally. It is beginning here."
"India Cements is a sell, the cement stocks are doing nothing but falling in spite of all the good news," he added.